GENOSPACE

Company Snapshot

Founded: 2011
Entity Type: Private
Region: U.S.
Headquarter: U.S.
Key Geographics: North America
Corporate Address: 27 School Street Boston Massachusetts 02108 U.S. Tel. +1-(617)-714-3420 www.genospace.com

Company Overview

GenoSpace, a wholly owned subsidiary of Sarah Cannon, develops software systems for storing, handling and analyzing genomic and health data. FullView allows clinical users to integrate results from multiple genomic and other diagnostic assays. It allows clinicians to better interpret clinical results and to generate molecular profiling reports.

GenoSpace has an alliance with Inova Health System, a nonprofit healthcare system, whereby Inova is using GenoSpace’s Population Analytics platform to analyze whole-genome NGS data.

GENOSPACE In Reports

Rare Disease Diagnostics: Technologies and Global Markets

Explore the rare disease diagnostics, including the DNA sequencing industry, PCR industry, laboratory services industry, etc.

Global DNA Read, Write and Edit Market

The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate of 20.5% during the period of 2019-2024.

Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023

Get an overview of the global markets for liquid biopsy technologies, applications, industry subsegments along with analyses of global market trends with data from 2017, 2018 and projections of CAGRs through 2023 ...

Company's Business Segments

  • Precision Medicine : The company integrates clinical, genomic, and real-world data to advance precision medicine through data-driven technologies, enabling informed decision-making, personalized treatment strategies, and improved patient outcomes.

Applications/End User Industries

  • Healthcare